The HIV-associated lipodystrophic syndrome (HIV-LDS) combines redistribution of fat mass with insulin resistance and hyperlipidemia. We have previously reported that HIV-LDS prevails in children in a comparable pattern as in adults. The metabolic activity itself of the lipodystrophic adipose tissue in HIV infection has been poorly studied. AIM AND METHODS: To assess in situ the insulin sensitivity of the lipohypertrophic subcutaneous abdominal adipose tissue using the microdialysis technique in HIV-infected children. Insulin sensitivity, assessed by the inhibition of glycerol release, was measured in the abdominal subcutaneous adipose tissue during a standard oral glucose tolerance test (OGTT) in six HIV-infected children under multi-therapy with abdominal lipohypertrophy (supra-iliac skinfold thickness > 97th percentile) (HIV=LHþ), in six obese children (obese group) and in eight HIV-infected children without lipodystrophy (HIV=LH7). RESULTS: Glucose tolerance was normal in all subjects. Mean insulin areas under the curve (IAUC) were significantly higher in the obese and HIV=LHþ groups than in HIV=LH7 (8769 AE 5429, 8161 AE 4552 and 3618 AE 2222 mU min l 71 , respectively; P ¼ 0.04 for the three groups comparison by the Kruskal -Wallis test), reflecting insulin resistance in the two former groups independent of a significant difference in percentage fat mass (37.2 AE 4.7, 22.8 AE 10.9 and 20.7 AE 7.1%, respectively; P ¼ 0.006). The crude inhibition of glycerol release, expressed as the relative change in dialysate glycerol concentration between baseline and 120 min, was not statistically different between the three groups (14% in obese, 738 AE 14% in HIV=LHþ and 751 AE 17% in HIV=LH7 groups; P ¼ 0.3). The inhibition of glycerol release with respect to the circulating insulin level (expressed by IAUC) was similar in HIV=LHþ and obese groups (76 AE 5 Â 10 73 and 77 AE 5 Â 10 73 l mU 71 min
Introduction
The HIV-associated lipodystrophy is made up of fat redistribution, consisting of peripheral fat loss or truncal fat accumulation; a mixed form, which is the combination of these is also observed. The HIV-related lipodystrophic syndrome (HIV-LDS) combines lipodystrophies with metabolic disturbances like insulin resistance and hyperlipidemia. The frequency of these disorders observed in several cross-sectional studies is highly variable. 1 -7 Diabetes is rare with a prevalence of 1 -7%, but insulin resistance is more frequent. This syndrome has been reported shortly after the initiation of highly active antiretroviral therapy (HAART), but the mechanism remains unknown. In the prospective studies implemented in patients under HAART, the incidence of lipodystrophy has been reported to be as high as 9% after 12 months or 17% after 18 months of follow-up. 8, 9 We have previously reported that HIV-LDS prevails in children in a similar pattern as in adults, although all features are less pronounced before puberty. 10 In the same cross-sectional study, clinical lipodystrophies were observed in one third of the HIV-infected children. These lipodystrophic children were insulin resistant in comparison to the non-lipodystrophic patients when insulin resistance was assessed by insulin circulating levels during OGTT in patients with normal glucose tolerance.
The metabolic activity itself of the adipose tissue in HIV infection has been poorly documented. It is therefore not known whether the morphological changes, and more specifically hypertrophy, are associated with specific metabolic dysfunctions. The microdialysis technique enables a local in vivo approach to follow the actual interstitial metabolic profile.
11,12
The aim of our study was to assess in situ the insulin sensitivity of the lipohypertrophic subcutaneous abdominal adipose tissue using the microdialysis technique in HIVinfected children by measuring the anti-lipolytic effect of insulin on glycerol release. Since we have previously shown that peripheral insulin resistance was observed under OGTT in HIV-infected children with lipodystrophy, we selected the same test in the present study. To distinguish metabolic changes in adipose tissue caused by HIV infection from that due to adipose tissue hypertrophy alone (obesity), we compared the results with those obtained in a group of obese, non-HIV-infected children, who were sex-and agematched with the HIV-lipohypertrophic patients.
Subjects and methods

Subjects
A total of 20 patients participated in the study (aged of 6 -8 y): 14 HIV-infected children and six non HIV-infected obese children. HIV-infected patients were included irrespective of their treatment and of metabolic disturbances. Nearly all of them were treated by HAART, including at least two nucleoside reverse transcriptase inhibitors and in most cases one protease inhibitor. HIV infection was generally well controlled as reflected by the CD4þ cell counts and by the viral mRNA levels ( Table 1) .
Non-inclusion criteria in all groups were age < 6 y, oral contraception, corticotherapy, acute infection and known defect of blood coagulation. An additional exclusion criterion was applied to HIV-infected children in whom partial or generalized lipoatrophy was confirmed by skinfold thickness values below the third percentile of the distribution for age and gender in four different areas.
13,14
The HIV-infected patients were selected into two groups with respect to the presence or not of subcutaneous abdominal hypertrophy defined as a supra-iliac skinfold thickness > 97th percentile of the distribution for gender and age. Six children had abdominal hypertrophy (HIV=LHþ group). The remaining children (n ¼ 8) did not show any lipodystrophy (HIV=LH7 group). A group of obese, non HIV-infected children (BMI > 25 kg=m 2 ) was used for comparison of metabolic functions of the adipose tissue. Abdominal hypertrophy, as defined above, was observed in all obese children. Gender distribution and frequency of children in prepuberty=puberty were similar in the three groups. 
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Children were included after informed parental consent and personal assent. The study was approved by the Ethical Committee of the St-Louis Medical School at the University of Paris.
Study protocol
Clinical data collection. Patients were admitted to the Clinical Investigation Unit at the Robert Debre hospital. Body height and weight were measured and body mass indexes (BMI) were calculated and read as Z-scores of the distribution for age and gender. 15 Puberty was quoted using Tanner stages. 16 Skinfold thicknessess (biceps, triceps, suprailiac, supra-scapular) were measured twice on the left side of the body by a harpender skinfold calliper (Chambly-Medical, Chambly, France) at a 5 min interval in each site. The two individual values for each site were averaged and were expressed as a percentile of the normal distribution for gender and age according to the French growth standard curves.
13,14 Trunk-to-arm ratio was calculated and expressed as a Z-score for gender and age. Percentage body fat mass was calculated after bioelectrical impedance analysis (BIA101Q, RJL Systems, Clintontownship, MI, USA).
Biological parameters. A standard oral glucose tolerance test (OGTT; 1.75 g glucose=kg body weight up to 75 g glucose) was performed after a 12 h overnight fast following the WHO recommendations. Plasma glucose and insulin levels were measured every 30 min until 120 min. Fasting serum lipids and glycerol levels were also measured.
The microdialysis technique. The method was similar as described by Lafontan et al 17 After a local anaesthesia, a microdialysis catheter. (30 Â 0.5 mm, 20 000 Da molecular weight cut-off) was inserted at both sizes of the umbilicus in the abdominal subcutaneous tissue at maximum 8 cm lateral to the umbilicus. The nylon tubing inlets of the catheters were connected to a microinjection pump. A Ringer solution supplemented with 4.0 mmol=l glucose was perfused through the catheters. After equilibration a recovery procedure was performed. Briefly, the catheters were perfused at three successive flow-rates. (3.0, 1.5 and 0.5 ml=min, respectively) and the glycerol concentrations were determined in the dialysate at the end of each perfusion period. (30 min). These concentrations were plotted against the perfusion rates. Regression analysis was used to calculate the glycerol concentration at 'zero flow'. The recovery rate of the catheter (%) at 0.5 ml=min was calculated by the ratio (glycerol concentration adipose tissue at 0.5 ml=min)= (interstitial glycerol concentration at 'zero flow') Â 100. The recovery rates were > 90% in all children. The perfusion rate was at 0.5 ml=min during the test.
Dialysate samples were collected for glycerol concentration measurements at 15 minutes interval during OGTT.
Analytical methods
Plasma and dialysate glycerol levels were measured by an automatic analyzer specifically designed for microdialysis samples (CMA 600 Microdialysis Analyser, Solna, Sweden). Glycerol was measured in the microdialysis analyzer by an optical system. The limit of detection was 10 mmol=l and CV was 3.7% at 12 mmol. Glucose was measured by a glucose oxydase method.
Serum insulin concentrations were measured using a double-antibody radio-immuno-assay (ERIA Diagnostics Pasteur, Paris, France). Cross-reactivity with proinsulin and the derived metabolites was less than 1%.
Plasma was assayed for HIV-RNA by a quantitative reverse transcriptase polymerase chain reaction assay (Amplicor Monitor, Roche-Diagnostic, Meylan, France). The lower limit of quantification was 200 copies per milliliter. CD4þ lymphocytes were quantified by flow cytometry.
Statistical analyses
All data were entered and analyzed on the SAS software (SAS Institute, Cary, NC, USA). Results are presented as mean AE 1 s.d. in the text and in the tables and for more clarity as mean AE 1 s.e. on the figures. Comparisons among the study groups for continuous variables were performed using non-parametric tests: a Kruskal -Wallis test for the three groups and a Mann -Whitney U-test for two groups. Values for insulin concentrations were log-transformed prior to analysis. Comparisons between the groups were performed taking into account an independent effect of BMI and gender using a GLM analysis.
Qualitative variables were compared using a w 2 or a Fisher exact test. The level of statistical significance was set at 0.05.
Results
Data on the study population are presented in Table 1 . There were no statistical differences in CD4þ cell count, in viral load and in distribution of HIV-therapy between HIV=LHþ and HIV=LH7 children. Anthropometric parameters were significantly different between the three groups (except for trunk to arm ratio), being consistently lower in the HIV=LH7 group. The HIV=LH7 children presented with BMI and skinfold thickness in the normal range for age and gender. The HIV=LHþ children showed BMI in the normal range but increased central skinfold thickness; moreover, the ratio of central to peripheral skinfold thickness was increased attesting for an abnormal fat distribution for age and gender.
Fasting cholesterol and triglycerides plasma levels were not significantly different between the groups. Plasma glycerol at fast was higher, although not significantly, in obese vs HIV-infected children (P ¼ 0.06). Results of the OGTT are presented in Figure 1 . All patients had normal glucose tolerance. Serum insulin concentrations at fast were higher, although not significantly, in HIV=LHþ group than in Figure 2 . No statistical differences were found between the three groups. Mean glycerol level at baseline was higher in obese vs HIV=LHþ children (P ¼ 0.2) and significantly higher in obese than in the HIV=LH7 group (P ¼ 0.03).
The inhibition of glycerol release, expressed as the relative change in glycerol level over baseline (glycerol T 120 7 T 0 = T 0 ), was not statistically different between the three groups (749 AE 14, 738 AE 14 and 751 AE 17% in the obese, HIV=LHþ and HIV=LH7 groups, respectively; P ¼ 0.3). The inhibition of glycerol release corrected for the level of circulating insulin during the OGTT (expressed by IAUC) was very similar in HIV=LHþ and obese groups (76 AE
Discussion
To our knowledge this is the first time that the metabolic activity of the adipose tissue of the HIV-associated lipodystrophies has been investigated in vivo. The microdialysis technique makes it possible to measure in situ the actual metabolic changes in the adipose tissue. Here we used the stimulation by insulin under OGTT and insulin sensitivity of the adipose tissue was assessed by inhibition of glycerol release in lipodystrophic areas in HIV-infected children.
The HIV=LHþ group presented with mild morphological changes. Indeed, there was a hypertrophy of the adipose tissue in the abdominal area according to our inclusion criteria. Otherwise most HIV=LHþ children had BMI calculated in the normal range for age and gender. In contrast, supra-iliac skinfolds were measured two-fold thicker in the Insulin resistance in the adipose tissue of HIV-lipodystrophies M Beregszàszi et al obese children than in the HIV-infected children with central hypertrophy. However, the degree of peripheral insulin resistance, assessed by IAUC together with normal glucose tolerance, was similar in the HIV=LHþ children and in obese children. This insulin resistance in the HIV-lipodystrophic children is not surprising since we have already reported elevated circulating insulin levels in HIV-infected children with lipodystrophy. Indeed it has been shown that the first stages of puberty induce insulin resistance 18 and that is the reason why the children in each study group were matched for gender and pubertal stage; therefore, differences in the level of insulin sensitivity between the lipodystrophic and not lipodystrophic children could not be explained by the effect of puberty. Moreover, mean BMI (expressed for age and gender) was lower in the HIV-infected children and could not therefore explain a similar degree of insulin resistance as in obese children. There was no statistical and independent effect of BMI on the comparisons of circulating insulin levels between these two groups. In contrast, in the non-lipodystrophic children normal glucose tolerance and low insulin levels were observed. It is therefore very unlikely that the peripheral insulin resistance observed in the HIVinfected children with lipohypertrophy were related to the HIV-infection itself.
The mechanism of HIV-LDS remains controversial and unclear. Several investigators have demonstrated that protease inhibitors (PIs) inhibit in vitro the preadipocyte differentiation. 19, 20 This could explain to some extent the process of lipodystrophy and the insulin resistance. It has been shown that PIs are able to inhibit in vitro the glucose transporter activity of GLUT-4 in an adipocyte-derived cell line, providing direct evidence for the mechanism of insulin resistance at the level of the adipocyte associated with the use of PI in HIV infection. 21 -23 One of this report also shows that nelfinavir is able to increase lipolysis in the same cell line. 22 Here, we provide another evidence of insulin resistance at the level of the adipose tissue. This observation is in keeping with the reports on the decrease of the whole peripheral glucose uptake in patients receiving PIs. 24, 25 It is well known that obesity is a risk factor for the development of insulin resistance even in populations with no increased genetic risk for type 2 diabetes. 26 If the resistance to the anti-lipolytic effect of insulin was due to the hypertrophy of the abdominal adipose tissue itself in the HIV-infected children it would be anticipated a lesser degree of insulin resistance than in the obese children in whom the abdominal wall was much thicker.
The in situ insulin sensitivity of the subcutaneous abdominal adipose tissue was similar in HIV=LHþ and in obese children whereas the metabolic activity of the adipose tissue at fast (dialysate glycerol adipose tissue T 0 ) was slightly lower in HIV=LHþ than in obese children. Although no information is available on the morphometry of the adipose tissue in lipodystrophies, it has been shown that the size of abdominal adipose cells interferes with the lipolytic rate.
27,28 It would be interesting to test whether the local stimulation of lipolysis is impaired in lipodystrophic patients in comparison to obese subjects. 12 In conclusion, our data argue in favor of insulin resistance in the adipose tissue in lipohypertophies associated with HIV infection. This adipose tissue showed a high degree of insulin resistance not anticipated from the modest anthropometric changes. This would suggest that adipocyte lesions contribute to the metabolic disturbances observed in the lipodystrophic syndrome associated with HIV infection.
